Patent Assignment
Reel/Frame 013774/0849
Assignment of Assignor's Interest
Recorded: 2001-11-29
Pages: 4
Assignor
HOECHST AKTIENGESELLSCHAFT
Executed: 2001-07-04
Assignee
AVENTIS PHARMA DEUTSCHLAND GMBH
INDUSTRIEPARK HOECHST, FRANKFURT AM MAIN, D-65926, GERMANY
Covered Properties
(28)
Cephem Derivatives and Processes for Their Manufacture
Patent:
4,758,556 →
Application:
05/891,850 →
Corticoid 17-(Alkyl Carbonates) and Processes for Their Preparation
Patent:
4,242,334 →
Application:
05/930,194 →
Method for Treating Hypertonia with N-(2-Furfuryl)-4-Chloro-5- Sulfamoyl-Anthranilic Acid and Preparations Thereof
Patent:
4,324,779 →
Application:
06/077,181 →
5-Methylisoxazole-4-Carboxylic-(4-Trifluoromethyl)-Anilids
Patent:
4,284,786 →
Application:
06/103,551 →
Process for the Manufacture of Lh-Rh and Lh-Rh Analogs Using (Glu-His(Dnp)-Oh
Patent:
4,275,001 →
Application:
06/120,924 →
Heterocyclic Substituted Sulfonyl Ureas, and Their Use
Patent:
4,379,785 →
Application:
06/217,524 →
Pharmaceutical Preparation and Method of Treatment
Patent:
4,351,841 →
Application:
06/239,986 →
Process for the Preparation of Compounds Containing Carboxylic Acid Amide Groups, in Particular or Peptides
Patent:
4,426,325 →
Application:
06/339,788 →
Cephalosporin Derivatives
Patent:
5,071,979 →
Application:
06/376,654 →
Pharmaceuticl Preparations in Solid Unit Dosage Form
Patent:
4,450,877 →
Application:
06/416,046 →
Substituted Pyrrolidinyl-Benzoic Acid Derivatives and a Process for Their Manufacture
Patent:
4,492,710 →
Application:
06/421,030 →
Aqueous Protein Solutions Stable to Denaturation
Patent:
4,783,441 →
Application:
06/564,346 →
Octahydroindole-2-Carboxylic Acids
Patent:
5,162,362 →
Application:
06/565,887 →
Decahydroisoquinoline-Carboxylic Acids
Patent:
5,158,959 →
Application:
06/565,900 →
Process for the Preparation of Human or the Derivatives Thereof from Pig Insulin or the Derivatives Thereof
Patent:
4,601,852 →
Application:
06/641,357 →
Method for Making -2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent:
4,727,160 →
Application:
06/658,902 →
Biclclic Aminoacids as Intermediates
Patent:
5,008,400 →
Application:
06/673,605 →
Crystalline Disodium Salt of Cefodizim
Patent:
4,590,267 →
Application:
06/770,406 →
Aqueous Protein Solutions Stable to Denaturation
Patent:
4,885,164 →
Application:
07/136,673 →
A Process for the Preparation of Cis, Endo-2- Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent:
4,879,403 →
Application:
07/267,753 →
Hirudin Derivative
Patent:
5,180,668 →
Application:
07/295,422 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids, a Process for Their Preparation, Agents Containing These Compounds and Their Use
Patent:
5,061,722 →
Application:
07/296,513 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-5-Carboxylic Acids
Patent:
5,053,519 →
Application:
07/318,519 →
Derivatives of Bicyclic Aminoacids Agents Containing These Compounds and Their Use
Patent:
4,933,361 →
Application:
07/346,339 →
Azarbicycloamino Carbocycloamino Acid Intermediates
Patent:
5,101,039 →
Application:
07/468,567 →
Cephem Derivatives
Patent:
35,754 →
Application:
07/551,615 →
Cephem Derivatives
Patent:
5,089,490 →
Application:
07/572,150 →
Aminoacid Derivatives, a Process for Their Preparation, Agents Containing These Compounds, and the Use Thereof
Patent:
5,401,766 →
Application:
08/208,443 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Aug 18, 2000
From: HOECHST MARION ROUSSEL DEUTSCHLAND GMBH
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 011019/0234 →
Assignment of Assignor's Interest
Apr 8, 2002
From: HOECHST AKTIENGESELLSCHAFT (HOECHST AG)
To: SCHERING AKTIENGESELLSCHAFT (SCHERING AG)
Reel/Frame 012785/0045 →
Assignment of Assignor's Interest
Aug 27, 2004
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: AVENTIS PHARMA S.A.
Reel/Frame 015035/0918 →
Assignment of Assignor's Interest
Aug 27, 2004
From: AVENTIS PHARMA S.A.
To: ABBOTT GMBH & CO. KG
Reel/Frame 015035/0920 →
Change of Name
Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Change of Name
Aug 20, 2008
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 021411/0374 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025741/0564 →
Release of Security Interest
Feb 4, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025746/0793 →